Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease

NCT02392780 is registered in ClinicalTrials.gov with moshe yeshurun as lead sponsor.

NCT NCT02392780
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02392780 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Cannabidiol for the Treatment of Severe (Grades III/IV) Acute Graft-versus-host Disease
Lead sponsor
moshe yeshurun
Phase
Phase 2
Overall status
Unknown status
Start date
April 30, 2015
Completion date
Not reported
Enrollment
10 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute-graft-versus-host disease